Skip to main content
Top
Published in: Trials 1/2019

Open Access 01-12-2019 | Heart Surgery | Study protocol

Multimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial

Authors: Pascal Chiari, Michel Durand, Olivier Desebbe, Marc-Olivier Fischer, Diane Lena-Quintard, Jean-Charles Palao, Catherine Mercier, Géraldine Samson, Yvonne Varillon, Matteo Pozzi, Nathan Mewton, Delphine Maucort-Boulch, Michel Ovize, Jean-Luc Fellahi

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Myocardial damage in patients undergoing cardiac surgery increases both morbidity and mortality. Different protective strategies dealing with either preconditioning or postconditioning or assessing a single aspect of cardioprotection have shown conflicting results. We tested the hypothesis that a multimodal approach would improve cardioprotection and limit myocardial damage following cardiac surgery with cardiopulmonary bypass.

Methods

This study is a pragmatic multicenter (six French institutions), prospective, randomized, single-blinded, controlled trial. The randomization is stratified by centers. In the study, 210 patients scheduled for aortic valve surgery with or without coronary artery bypass grafting will be assigned to a control or a treatment group (105 patients in each group). In the control group, patients receive total intravenous anesthesia with propofol and liberal intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 60 min, is greater than 180 mg/dl), as a standard of care. The treatment group receives a bundle of care combining five techniques of cardioprotection: (1) remote ischemic preconditioning applied before aortic cross-clamping; (2) maintenance of anesthesia with sevoflurane; (3) tight intraoperative blood glucose management (initiation of insulin infusion when blood glucose, measured every 30 min, is greater than 140 mg/dl); (4) moderate respiratory acidosis (pH 7.30) at the end of cardiopulmonary bypass; and (5) a gentle reperfusion protocol following aortic unclamping. The primary outcome is myocardial damage measured by postoperative 72-h area under the curve of high-sensitivity cardiac troponin I.

Discussion

The ProCCard study will be the first multicenter randomized controlled trial aiming to assess the role of a bundle of care combining several cardioprotective strategies to reduce myocardial damage in patients undergoing cardiac surgery with cardiopulmonary bypass.

Trial registration

ClinicalTrials.gov, NCT03230136. Registered on July 26, 2017. Last updated on April 17, 2019.

Literature
  1. Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation. 2006;114:1468–75. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​105.​602370.View ArticlePubMed
  2. Fellahi JL, Gue X, Richomme X, Monier E, Guillou L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003;99:270–4.View Article
  3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36.View Article
  4. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88. https://​doi.​org/​10.​1152/​ajpheart.​01064.​2002.View ArticlePubMed
  5. Lefer DJ, Marban E. Is cardioprotection dead? Circulation. 2017;136:98–109. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​116.​027039.View ArticlePubMedPubMed Central
  6. Chiari P, Angoulvant D, Mewton N, Desebbe O, Obadia JF, Robin J, Farhat F, Jegaden O, Bastien O, Lehot JJ, Ovize M. Cyclosporine protects the heart during aortic valve surgery. Anesthesiology. 2014;121:232–8. https://​doi.​org/​10.​1097/​ALN.​0000000000000331​.View ArticlePubMed
  7. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101:299–310.View Article
  8. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575–9. https://​doi.​org/​10.​1016/​S0140-6736(07)61296-3.View ArticlePubMed
  9. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology. 2005;102:102–9.View Article
  10. Gu W, Kehl F, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. Anesthesiology. 2008;108:634–42. https://​doi.​org/​10.​1097/​ALN.​0b013e3181672590​.View ArticlePubMedPubMed Central
  11. Kitakaze M, Takashima S, Funaya H, Minamino T, Node K, Shinozaki Y, Mori H, Hori M. Temporary acidosis during reperfusion limits myocardial infarct size in dogs. Am J Phys. 1997;272:H2071–8. https://​doi.​org/​10.​1152/​ajpheart.​1997.​272.​5.​H2071.View Article
  12. Inserte J, Barba I, Hernando V, Garcia-Dorado D. Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res. 2009;81:116–22. https://​doi.​org/​10.​1093/​cvr/​cvn260.View ArticlePubMed
  13. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63. https://​doi.​org/​10.​1001/​jama.​1993.​03510240069035.View ArticlePubMed
  14. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC. Isoflurane mimics ischemic preconditioning via activation of K (ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87:361–70.View Article
  15. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, Pons A, Lehot JJ. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth. 2007;99:624–31. https://​doi.​org/​10.​1093/​bja/​aem264.View ArticlePubMed
  16. De Hert SG, Vlasselaers D, Barbe R, Ory JP, Dekegel D, Donnadonni R, Demeere JL, Mulier J, Wouters P. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009;64:953–60. https://​doi.​org/​10.​1111/​j.​1365-2044.​2009.​06008.​x.View ArticlePubMed
  17. Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, Görlich D, Kellum JA, Meersch M, for the RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery A randomized clinical trial. JAMA. 2015;313:2133–41. https://​doi.​org/​10.​1001/​jama.​2015.​4189.View ArticlePubMed
  18. Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, for the ERICCA Trial Investigators. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408–17. https://​doi.​org/​10.​1056/​NEJMoa1413534.View ArticlePubMed
  19. Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K, for the RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397–407. https://​doi.​org/​10.​1056/​NEJMoa1413579.View ArticlePubMed
  20. Hanouz JL, Zhu L, Lemoine S, Durand C, Lepage O, Massetti M, Khayat A, Plaud B, Gerard JL. Reactive oxygen species mediate sevoflurane- and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg. 2007;105:1534–9. https://​doi.​org/​10.​1213/​01.​ane.​0000286170.​22307.​1a.View ArticlePubMed
  21. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes. Roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology. 2008;108:612–20. https://​doi.​org/​10.​1097/​ALN.​0b013e318167af2d​.View ArticlePubMedPubMed Central
  22. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75:S715–20. https://​doi.​org/​10.​1016/​S0003-4975(02)04701-X.View ArticlePubMed
  23. Fellahi J-L, Hedoire F, Le Manach Y, Monier E, Guillou L, Riou B. Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgery. Crit Care. 2007;11:R106. https://​doi.​org/​10.​1186/​cc6126.View ArticlePubMedPubMed Central
  24. Ascione R, Rogers CA, Rajakaruna C, Angelini GD. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation. 2008;118:113–23. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​107.​706416.View ArticlePubMedPubMed Central
  25. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002;96:183–8.View Article
  26. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand. 2012;56:30–8. https://​doi.​org/​10.​1111/​j.​1399-6576.​2011.​02585.​x.View ArticlePubMed
  27. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013;382:597–604. https://​doi.​org/​10.​1016/​S0140-6736(13)61450-6.View ArticlePubMed
  28. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191–8.View Article
  29. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010;112:860–71. https://​doi.​org/​10.​1097/​ALN.​0b013e3181d3d4b4​.View ArticlePubMed
  30. Duncan AE, Sessler DI, Sato H, Sato T, Nakazawa K, Carvalho G, Hatzakorzian R, Codere-Maruyama T, Abd-Elsayed A, Bose S, Said T, Mendoza-Cuartas M, Chowdary H, Mascha EJ, Yang D, Gillinov AM, Schricker T. Hyperinsulinemic normoglycemia during cardiac surgery reduces a composite of 30-day mortality and serious in-hospital complications: A randomized clinical trial. Anesthesiology. 2018;128:1125–39. https://​doi.​org/​10.​1097/​ALN.​0000000000002156​.View ArticlePubMedPubMed Central
  31. Bond JM, Harper IS, Chacon E, Reece JM, Herman B, Lemasters JJ. The pH paradox in the pathophysiology of reperfusion injury to rat neonatal cardiac myocytes. Ann N Y Acad Sci. 1994;723:25–37. https://​doi.​org/​10.​1111/​j.​1749-6632.​1994.​tb36714.​x.View ArticlePubMed
  32. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res. 2006;69:178–85. https://​doi.​org/​10.​1016/​j.​cardiores.​2005.​07.​014.View ArticlePubMed
Metadata
Title
Multimodal cardioprotective strategy in cardiac surgery (the ProCCard trial): Study protocol for a multicenter randomized controlled trial
Authors
Pascal Chiari
Michel Durand
Olivier Desebbe
Marc-Olivier Fischer
Diane Lena-Quintard
Jean-Charles Palao
Catherine Mercier
Géraldine Samson
Yvonne Varillon
Matteo Pozzi
Nathan Mewton
Delphine Maucort-Boulch
Michel Ovize
Jean-Luc Fellahi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3638-3

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue